| 注册

6种姜科傣药研究进展

戴相仙 谭慧 马海静 阳红燕 金琼 谭文红

云南民族大学学报(自然科学版)2026,Vol.35Issue(1):17-22,51,7.
云南民族大学学报(自然科学版)2026,Vol.35Issue(1):17-22,51,7.DOI:10.3969/j.issn.1672-8513.2026.01.003

6种姜科傣药研究进展

Research progress on six species of Zingiberaceae Dai medicinal plants

戴相仙 1谭慧 2马海静 3阳红燕 4金琼 4谭文红5

作者信息

  • 1. 云南中医药大学民族医药学院,云南 昆明 650000
  • 2. 云南中医药大学民族医药学院,云南 昆明 650000||云南中医药大学中药学院,云南 昆明 650000
  • 3. 云南省傣医药与彝医药重点实验室,云南 昆明 650000
  • 4. 云南中医药大学中药学院,云南 昆明 650000
  • 5. 云南中医药大学民族医药学院,云南 昆明 650000||云南省傣医药与彝医药重点实验室,云南 昆明 650000
  • 折叠

摘要

Abstract

Dai medicine,a traditional Chinese medicinal system developed by the Dai ethnic minority in Yunnan Province,has been widely utilized due to it is unique geographical environment and other reasons.Selects six commonly used Dai ethnic medicines from the Zingiberaceae family:Alpinia galanga(L.)Willd.,A.kwangsiensis T.L.Wu et SenJen Chen,Amomum maximum Roxb.,Costus speciosus(Koen.)Smith,Hedychium flavum Roxb.,and Zingiber montanum(J.Koenig)Link ex A.Dietr.By summarizing the traditional applications,chemical components,pharmacological effects and quality standards of these six medicines,it is found that these six medicines mainly contain a variety of chemical components such as volatile oils,flavonoids,terpenoids,phenylpropanoids,phenols and steroids,and have pharmacological effects such as antibacterial,anti-inflammatory,antioxidant,anti-cancer,hypoglycemic and liver-protecting effects.However,their quality standard systems are imperfect and the development of related products is rather single.Through this review,it provides a basis and ideas for the follow-up research and development of Dai ethnic medicines from the Zingiberaceae family and expands their application scope.

关键词

姜科傣药/传统应用/化学成分/药理作用/质量控制

Key words

Zingiberaceae family/traditional applications/chemical components/pharmacological effects/quality standards

分类

医药卫生

引用本文复制引用

戴相仙,谭慧,马海静,阳红燕,金琼,谭文红..6种姜科傣药研究进展[J].云南民族大学学报(自然科学版),2026,35(1):17-22,51,7.

基金项目

云南省生物医药重大专项(202302AA3100006) (202302AA3100006)

云南省教育厅民族药物质基准研究重点实验室(2022YGZ02) (2022YGZ02)

国家中医药管理局重点学科傣药学 ()

云南省基础研究中医联合专项(202001AZ070001-025). (202001AZ070001-025)

云南民族大学学报(自然科学版)

1672-8513

访问量1
|
下载量0
段落导航相关论文